Literature DB >> 17628517

Antioxidant status and superoxide anion radical generation in acute myeloid leukemia.

Tze-Kiong Er1, Shih-Meng Tsai, Szu-Hsien Wu, Wen Chiang, Hsien-Cheng Lin, Sheng-Fung Lin, Szu-Hua Wu, Li-Yu Tsai, Tsan-Zon Liu.   

Abstract

OBJECTIVES: This study was undertaken to investigate if there is a disparity in the antioxidant status and the ability of superoxide anion (O(2)(-)) generation in the patients with acute myeloid leukemia (AML). DESIGN AND METHODS: The peripheral blood samples from thirty AML patients and thirty-six healthy subjects were collected and leukocytes, erythrocytes and plasma were separated for use in various parameter measurements.
RESULTS: The generation of O(2)(-), as reflected by lucigenin-based CL (LBCL), by the leukocytes of patients with AML was found to be significantly elevated either in resting or stimuli-elicited condition as compared with that of healthy controls (p<0.05). Coincidentally, these data were matched up with the suppressed SOD activities, notably in Cu/Zn SOD isoform found in AML patients (p<0.05). Conversely, SOD and GPx activities in erythrocytes of patients with AML were shown to be significantly higher than their normal counterparts (p<0.05).
CONCLUSIONS: These data suggest that altered expression of antioxidant enzymes and higher capability of O(2)(-) generation by leukocytes seem to be a distinct feature of AML.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17628517     DOI: 10.1016/j.clinbiochem.2007.05.013

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  14 in total

1.  Comparing serum levels of zinc, copper, certain antioxidant vitamins and dietary intakes in acute lymphoblastic leukemia (ALL) patients before and after chemotherapy.

Authors:  Camellia Akhgarjand; Kurosh Djafarian; Hamid Rezvani; Eznollah Azargashb; Mohammadreza Vafa
Journal:  Am J Blood Res       Date:  2018-10-05

2.  H2O2/Peroxynitrite-Activated Hydroxamic Acid HDAC Inhibitor Prodrugs Show Antileukemic Activities against AML Cells.

Authors:  Yi Liao; Liping Xu; Siyu Ou; Holly Edwards; Daniel Luedtke; Yubin Ge; Zhihui Qin
Journal:  ACS Med Chem Lett       Date:  2018-06-13       Impact factor: 4.345

3.  Rational Design of a Parthenolide-based Drug Regimen That Selectively Eradicates Acute Myelogenous Leukemia Stem Cells.

Authors:  Shanshan Pei; Mohammad Minhajuddin; Angelo D'Alessandro; Travis Nemkov; Brett M Stevens; Biniam Adane; Nabilah Khan; Fred K Hagen; Vinod K Yadav; Subhajyoti De; John M Ashton; Kirk C Hansen; Jonathan A Gutman; Daniel A Pollyea; Peter A Crooks; Clayton Smith; Craig T Jordan
Journal:  J Biol Chem       Date:  2016-08-29       Impact factor: 5.157

Review 4.  Redox control of leukemia: from molecular mechanisms to therapeutic opportunities.

Authors:  Mary E Irwin; Nilsa Rivera-Del Valle; Joya Chandra
Journal:  Antioxid Redox Signal       Date:  2012-09-28       Impact factor: 8.401

Review 5.  Novel roles of reactive oxygen species in the pathogenesis of acute myeloid leukemia.

Authors:  Fuling Zhou; Qiang Shen; François X Claret
Journal:  J Leukoc Biol       Date:  2013-05-28       Impact factor: 4.962

6.  Depletion of the chromatin remodeler CHD4 sensitizes AML blasts to genotoxic agents and reduces tumor formation.

Authors:  Justin Sperlazza; Mohamed Rahmani; Jason Beckta; Mandy Aust; Elisa Hawkins; Shou Zhen Wang; Sheng Zu Zhu; Shreya Podder; Catherine Dumur; Kellie Archer; Steven Grant; Gordon D Ginder
Journal:  Blood       Date:  2015-08-11       Impact factor: 22.113

7.  Targeting aberrant glutathione metabolism to eradicate human acute myelogenous leukemia cells.

Authors:  Shanshan Pei; Mohammad Minhajuddin; Kevin P Callahan; Marlene Balys; John M Ashton; Sarah J Neering; Eleni D Lagadinou; Cheryl Corbett; Haobin Ye; Jane L Liesveld; Kristen M O'Dwyer; Zheng Li; Lei Shi; Patricia Greninger; Jeffrey Settleman; Cyril Benes; Fred K Hagen; Joshua Munger; Peter A Crooks; Michael W Becker; Craig T Jordan
Journal:  J Biol Chem       Date:  2013-10-02       Impact factor: 5.157

8.  Glutamate-cysteine ligase catalytic subunit as a therapeutic target in acute myeloid leukemia and solid tumors.

Authors:  Chiou-Hong Lin; John P Vu; Chen-Yen Yang; Mint Sirisawad; Chun-Te Chen; Hung Dao; Jing Liu; Xuan Ma; Chin Pan; Joseph Cefalu; Chris Tse; Erica Jackson; Hsu-Ping Kuo
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

9.  Spectroscopic study of 2-(2-pyridyliminomethyl)phenol as a novel fluorescent probe for superoxide anion radicals and superoxide dismutase activity.

Authors:  Shuhui Ma; Wei Mu; Jigang Gao; Jie Zhou
Journal:  J Fluoresc       Date:  2008-11-11       Impact factor: 2.217

Review 10.  Oxidative stress, bone marrow failure, and genome instability in hematopoietic stem cells.

Authors:  Christine Richardson; Shan Yan; C Greer Vestal
Journal:  Int J Mol Sci       Date:  2015-01-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.